Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06528626
What this trial is testing

Tools to Identify People At Risk or Already Infected with HIV and HCV

Who this might be right for
HIV/AIDSSTDHCV
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 240,000
Early research (Phase 1)Study completedNCT00489385
What this trial is testing

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Who this might be right for
HIV InfectionsHCV
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableStudy completedNCT03369743
What this trial is testing

Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 125
Not applicableStudy completedNCT02696681
What this trial is testing

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention

Who this might be right for
Human Immunodeficiency VirusDepressionMental Health
University of Miami 27
Testing effectiveness (Phase 2)Study completedNCT05064956
What this trial is testing

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Who this might be right for
Ebola Virus DiseaseEbolaHiv
London School of Hygiene and Tropical Medicine 26
Large-scale testing (Phase 3)Ended earlyNCT00028067
What this trial is testing

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Large-scale testing (Phase 3)Study completedNCT00262106
What this trial is testing

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

Who this might be right for
HIV InfectionsGonorrheaChlamydial Infections+1 more
Endo USA Inc., a Keenova Therapeutics Company 9,404
Early research (Phase 1)Study completedNCT02194179
What this trial is testing

Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 92
Not applicableStudy completedNCT05382130
What this trial is testing

INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya

Who this might be right for
COVID-19
Elizabeth Glaser Pediatric AIDS Foundation 152,082
Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Early research (Phase 1)Study completedNCT00000876
What this trial is testing

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Testing effectiveness (Phase 2)Study completedNCT00951015
What this trial is testing

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 208
Not applicableStudy completedNCT00002035
What this trial is testing

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

Who this might be right for
HIV Infections
Bristol-Myers Squibb 300
Not applicableStudy completedNCT02427204
What this trial is testing

Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality

Who this might be right for
Hepatitis C Infection
Icahn School of Medicine at Mount Sinai 150
Not applicableStudy completedNCT03324009
What this trial is testing

2-stage Cervical Cancer Screening in Botswana

Who this might be right for
Cervical CancerHIV/AIDS
Beth Israel Deaconess Medical Center 239
Early research (Phase 1)Study completedNCT00854204
What this trial is testing

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

Who this might be right for
HIV-I
Tibotec Pharmaceuticals, Ireland 12
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Testing effectiveness (Phase 2)Looking for participantsNCT07681089
What this trial is testing

Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

Who this might be right for
Liver Cirrhosis
Kiminori Kimura, MD 4
Post-approval studies (Phase 4)Study completedNCT00648817
What this trial is testing

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Who this might be right for
HIV Infections
Gilead Sciences 8
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Next Page